Evidence map›Paper›PMID 21799916›Full record

ArticlePloS one2011

Imaging of alkaline phosphatase activity in bone tissue.

Terence P Gade, Matthew W Motley, Bradley J Beattie, Roshni Bhakta, Adele L Boskey, Jason A Koutcher, Philipp Mayer-Kuckuk

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. A high throughput assay for phosphoribosylformylglycinamidine synthase.SLAS discovery : advancing life sciences R & D · 2025
    Article
  3. Article
  4. Article
  5. Fluorogenic probes for imaging cellular phosphatase activity.Current opinion in chemical biology · 2020
    Review
  6. Article
  7. Article
  8. New frontiers and developing applications in 19F NMR.Progress in nuclear magnetic resonance spectroscopy · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Terence P GadeBone Cell Biology and Imaging Laboratory, Hospital for Special Surgery, New York, New York, United States of America.
Matthew W Motley
Bradley J Beattie
Roshni Bhakta
Adele L Boskey
Jason A Koutcher
Philipp Mayer-Kuckuk
Memorial Sloan Kettering Cancer Center · USHospital for Special Surgery · US

Funding

Memorial Sloan Kettering Small Animal Imaging ResearchR24CA083084 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI KOUTCHER, JASON ARTHUR · 1999 to 2006
$4.4M
OSTEOGENESIS AND REPAIR IN LIVING INTACT BONER01AR055294 · NIAMS · HOSPITAL FOR SPECIAL SURGERY · PI MAYER-KUCKUK, PHILIPP · 2008 to 2011
$1.5M
In Vivo Imaging of Osteoblast RegulationR03AR052069 · NIAMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI MAYER-KUCKUK, PHILIPP · 2005 to 2007
$256k
NCI NIH HHS R24 CA083084NCI NIH HHS R24CA083084NIAMS NIH HHS R01 AR055294NIAMS NIH HHS R01AR055294NIAMS NIH HHS R03 AR052069NIAMS NIH HHS R03AR052069
6 · The paper itself

Abstract

The purpose of this study was to develop a paradigm for quantitative molecular imaging of bone cell activity. We hypothesized the feasibility of non-invasive imaging of the osteoblast enzyme alkaline phosphatase (ALP) using a small imaging molecule in combination with (19)Flourine magnetic resonance spectroscopic imaging ((19)FMRSI). 6, 8-difluoro-4-methylumbelliferyl phosphate (DiFMUP), a fluorinated ALP substrate that is activatable to a fluorescent hydrolysis product was utilized as a prototype small imaging molecule. The molecular structure of DiFMUP includes two Fluorine atoms adjacent to a phosphate group allowing it and its hydrolysis product to be distinguished using (19)Fluorine magnetic resonance spectroscopy ((19)FMRS) and (19)FMRSI. ALP-mediated hydrolysis of DiFMUP was tested on osteoblastic cells and bone tissue, using serial measurements of fluorescence activity. Extracellular activation of DiFMUP on ALP-positive mouse bone precursor cells was observed. Concurringly, DiFMUP was also activated on bone derived from rat tibia. Marked inhibition of the cell and tissue activation of DiFMUP was detected after the addition of the ALP inhibitor levamisole. (19)FMRS and (19)FMRSI were applied for the non-invasive measurement of DiFMUP hydrolysis. (19)FMRS revealed a two-peak spectrum representing DiFMUP with an associated chemical shift for the hydrolysis product. Activation of DiFMUP by ALP yielded a characteristic pharmacokinetic profile, which was quantifiable using non-localized (19)FMRS and enabled the development of a pharmacokinetic model of ALP activity. Application of (19)FMRSI facilitated anatomically accurate, non-invasive imaging of ALP concentration and activity in rat bone. Thus, (19)FMRSI represents a promising approach for the quantitative imaging of bone cell activity during bone formation with potential for both preclinical and clinical applications.

Indexed as

Alkaline PhosphataseAnimalsBone and BonesCattleCell LineExtracellular SpaceHydrolysisHymecromoneMagnetic Resonance SpectroscopyMiceMolecular ImagingRats6,8-difluoro-4-methylumbelliferyl phosphateAlkaline PhosphataseHymecromone

Identifiers

PMID21799916
PMCPMC3143164
OpenAlexW2009802493

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.